GW&K Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43K Sell
110
-10
-8% -$4.23K ﹤0.01% 625
2026
Q1
$57K Sell
120
-3
-2% -$1.51K ﹤0.01% 537
2025
Q4
$57K Buy
123
+2
+2% +$929 ﹤0.01% 528
2025
Q3
$52K Buy
121
+2
+2% +$775 ﹤0.01% 525
2025
Q2
$46K Buy
119
+17
+17% +$6.13K ﹤0.01% 528
2025
Q1
$35K Sell
102
-2
-2% -$643 ﹤0.01% 540
2024
Q4
$31K Buy
104
+6
+6% +$2.1K ﹤0.01% 540
2024
Q3
$40K Buy
98
+23
+31% +$8.42K ﹤0.01% 484
2024
Q2
$24K Buy
75
+10
+15% +$3.25K ﹤0.01% 534
2024
Q1
$22K Sell
65
-2
-3% -$611 ﹤0.01% 528
2023
Q4
$18K Sell
67
-10
-13% -$2.47K ﹤0.01% 525
2023
Q3
$19K Hold
77
﹤0.01% 492
2023
Q2
$23K Buy
+77
New +$21.4K ﹤0.01% 457
2022
Q3
Sell
-422
Closed -$71K 586
2022
Q2
$71K Buy
422
+15
+4% +$3.22K ﹤0.01% 365
2022
Q1
$102K Buy
+407
New +$102K ﹤0.01% 349

Other funds holding HCA

GW&K Investment Management's HCA Position: Q2 2026 in Review

GW&K Investment Management reduced its HCA Healthcare (HCA) stake by 8.3% in Q2 2026, selling an estimated $4.23K and leaving 110 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #625.

GW&K Investment Management first reported a position in HCA in Q1 2022 and has held it in 15 quarters since. The position peaked at $102K in Q1 2022. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • GW&K Investment Management held 110 shares of HCA Healthcare worth $43K as of Q2 2026.
  • GW&K Investment Management sold 10 HCA Healthcare shares in Q2 2026, an estimated $4.23K.
  • HCA Healthcare made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #625 holding.
  • GW&K Investment Management first reported a position in HCA Healthcare in Q1 2022 and has held it in 15 quarters since.
  • GW&K Investment Management's HCA Healthcare position peaked at $102K in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.